Advances in Microneedle‐Based Technology for Disease Detection via Interstitial Fluid
Macromolecular Bioscience · 2026
DOI: 10.1002/mabi.70265 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Macromolecular Bioscience, 2026. Verfasst von Lan Yu und 3 weiteren Autor:innen. Beteiligte Einrichtung: College of Medical Technology, Gannan Health Vocational College, Ganzhou, Jiangxi, People's Republic of China. Hauptthemen laut MEDLINE: Extracellular Fluid, Needles, Biosensing Techniques. Die Arbeit nennt 174 Literaturangaben. Gefördert von: Early-Career Young Scientists and Technologists Project of Jiangxi Province, The start-up funds from Gannan Health Vocational College, Jiangxi Provincial Research Project on Teaching Reform in Vocational and Adult Education.
Abstract (Originalsprache)
Conventional blood‐based diagnostics provide essential clinical information but can be less suitable for frequent or continuous biomarker monitoring because they generally require repeated invasive sampling and laboratory‐based analysis. Microneedle platforms provide minimally invasive access to dermal interstitial fluid (ISF) and can couple transdermal sampling with on‐needle or in situ sensing. This review critically summarizes the microneedle diagnostic systems by comprehensively considering the microneedle architecture, material and polymer properties, mechanical design, sensing modality, disease‐specific biomarker requirements and translational performance. Solid, hollow, coated, dissolving, and hydrogel microneedles are discussed together with recent advances in polymer structure–property engineering and 3D‐printed microneedle platforms. Electrical/electrochemical, optical, and Raman‐based sensing strategies are comparatively evaluated, followed by their applications in metabolic, oncological, inflammatory, allergic, stress‐related, and renal disorders. Particular attention is given to the trade‐offs among mechanical reliability, ISF transport, analytical sensitivity, biofouling, signal stability, manufacturing reproducibility, and clinical validation. Finally, scalable manufacturing, regulatory translation, wearable integration, and artificial‐intelligence‐assisted analysis are discussed as key requirements for moving microneedle diagnostics from proof‐of‐concept devices toward reliable personalized and decentralized healthcare.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Medical Technology, Gannan Health Vocational College, Ganzhou, Jiangxi, People's Republic of China.
- Shaanxi Key Laboratory of Natural Products & Chemical Biology, College of Chemistry & Pharmacy, Northwest A&F University, Yangling, Shaanxi, People's Republic of China.
- School of Basic Medicine, Gannan Medical University, Ganzhou, Jiangxi, People's Republic of China.
ORCID-Profile: Weiqiang Han
Förderung
- Early-Career Young Scientists and Technologists Project of Jiangxi Province
- The start-up funds from Gannan Health Vocational College
- Jiangxi Provincial Research Project on Teaching Reform in Vocational and Adult Education
Zitieren
APA
Yu, L., Liu, G., Ouyang, F., & Han, W. (2026). Advances in Microneedle‐Based Technology for Disease Detection via Interstitial Fluid. Macromolecular Bioscience. https://doi.org/10.1002/mabi.70265
Vancouver
Yu L, Liu G, Ouyang F, Han W. Advances in Microneedle‐Based Technology for Disease Detection via Interstitial Fluid. Macromolecular Bioscience. 2026. doi:10.1002/mabi.70265
BibTeX
@article{Yu2026,
author = {Yu, Lan and Liu, Guoxin and Ouyang, Feng and Han, Weiqiang},
title = {Advances in Microneedle‐Based Technology for Disease Detection via Interstitial Fluid},
journal = {Macromolecular Bioscience},
year = {2026},
doi = {10.1002/mabi.70265}
}
EUVIMED